The prognostic and incremental value of T1 mapping for predicting adverse events in hypertrophic cardiomyopathy

1 September 2024 (13:55 - 14:05)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Doctor Jie Wang

West China Hospital, Sichuan University, Chengdu (China)

4 More presentations in this session

Presentation thumbnail

Incremental prognostic value of late gadolinium enhancement granularity in patients with hypertrophic cardiomyopathy

Mr J. Florence (Paris, FR)

Abstract Slides Video

Presentation thumbnail

Revisiting risk stratification in hypertrophic cardiomyopathy after the recent guidelines - LGE remains tough to beat

Doctor R. Amador (Lisbon, PT)

Abstract Slides Video

Presentation thumbnail

Left atrioventricular coupling index is an independent associate of new-onset AF and stroke in hypertrophic cardiomyopathy: a CMR study

Doctor M. De Raffele (Ferrara, IT)

Abstract Slides Video

Presentation thumbnail

CMR-derived pulmonary artery to aorta ratio as a predictor of adverse outcome in patients with cardiac transthyretin amyloidosis

Doctor C. Kronberger (Vienna, AT)

Abstract Slides Video

Access the full session

Session thumbnail

Prognostication in left ventricular hypertrophy: role of cardiac magnetic resonance imaging

The Event

Event poster

ESC Congress 2024

1 September 2024 13:55 CET

You may be interested in

Congress Session

Prognostication in left ventricular hypertrophy: role of cardiac magnetic resonance imaging

Congress Presentation

Enhanced risk stratification in hypertrophic cardiomyopathy through the integration of extracellular volume fraction on cardiovascular magnetic resonance

Congress Session

Prognostic imaging in hypertrophic cardiomyopathy and amyloidosis

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources